Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F47DB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,887
Award facts
- Contract value 100% obligated
- $24,887.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $24.9K to AmerisourceBergen Drug Corp for the supply of Skyrizi 150 mg/ml pen injections. This firm fixed-price delivery order, issued on January 8, 2026, is set to conclude by January 9, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded non-set-aside contract, demonstrating the contractor's capability to meet federal pharmaceutical procurement requirements through open competition.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.99M through December 2026. The parent company, Cencora, Inc. (operating as AmerisourceBergen), maintains an even larger IDC with DLA valued at up to $999.99M through December 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Skyrizi, a biologic medication used in dermatological treatments, represents one of the specialized pharmaceutical products within the company's extensive portfolio supporting military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F47DB?
SPE2DR26F47DB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F47DB worth?
The government has obligated $24,887 on SPE2DR26F47DB.
Is contract SPE2DR26F47DB an order under another contract?
Yes. SPE2DR26F47DB is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47DB competed?
The extent of competition for SPE2DR26F47DB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award